Cardiogenic Shock Intravascular Cooling Trial (CHILL-SHOCK)
Journal of Cardiac Failure · 2024
DOI: 10.1016/j.cardfail.2024.02.017 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cardiac Failure, 2024. Verfasst von Nikhil Gupta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Chicago, Chicago, IL. Hauptthemen laut MEDLINE: Shock, Cardiogenic, Hypothermia, Induced. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: ZOLL Foundation.
Abstract (Originalsprache)
BACKGROUND: Cardiogenic shock (CS) is complicated by high mortality rates. Targeted temperature control (TTC) has been proposed as an adjunct therapy in CS. This study aims to examine the safety of TTC in patients presenting with CS. METHODS AND RESULTS: In this open-label, randomized controlled pilot trial, 20 patients with hemodynamic criteria for CS were assigned to standard of care plus TTC vs standard of care alone. The primary outcome was a composite safety outcome, including well-described complications of TTC. Secondary outcomes included mortality at 90 days, invasive hemodynamic and echocardiographic parameters, electrocardiographic measurements, and inotrope dosing. There were no significant differences in the composite analysis of prespecified safety outcomes (3 events in the TTC group vs 0 events in the control group; P = 0.24). Patients randomized to TTC demonstrated a statistically significant increase in cardiac index and cardiac power index compared to the control group at 48-96 hours after randomization (3.6 [3.1, 3.9] L/min/m2 vs 2.6 [2.5, 3.15] L/min/m2; P = 0.029 and 0.61 [0.55, 0.7] W/m2 vs 0.53 [0.435, 0.565] W/m2; P = 0.029, respectively). CONCLUSION: TTC may be a safe adjunct therapy for patients presenting with CS and may yield improvement in specific hemodynamic parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Chicago, Chicago, IL.
- Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD.
- Division of Cardiology, Ascension, Chicago, IL.
- Section of Cardiology, Department of Medicine, University of Chicago, Chicago, IL.
- School of Computing, DePaul University, Chicago, IL.
- Division of Cardiology, University of Washington, Seattle, WA.
Förderung
- ZOLL Foundation
Zitieren
APA
Gupta, N., Kalathiya, R. J., Singh, N., Bandealy, N., Neyestanak, M., Besser, S., Arevalo, C., Friant, J., Blair, J. E. A., Nathan, S., Shah, A. P., & Paul, J. (2024). Cardiogenic Shock Intravascular Cooling Trial (CHILL-SHOCK). Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2024.02.017
Vancouver
Gupta N, Kalathiya RJ, Singh N, Bandealy N, Neyestanak M, Besser S, et al. Cardiogenic Shock Intravascular Cooling Trial (CHILL-SHOCK). Journal of Cardiac Failure. 2024. doi:10.1016/j.cardfail.2024.02.017
BibTeX
@article{Gupta2024,
author = {Gupta, Nikhil and Kalathiya, Rohan J and Singh, Nikhil and Bandealy, Nadeem and Neyestanak, Maryam and Besser, Stephanie and Arevalo, Cynthia and Friant, Janet and Blair, John E A and Nathan, Sandeep and Shah, Atman P and Paul, Jonathan},
title = {Cardiogenic Shock Intravascular Cooling Trial (CHILL-SHOCK)},
journal = {Journal of Cardiac Failure},
year = {2024},
doi = {10.1016/j.cardfail.2024.02.017}
}
EUVIMED